Chimioth??rapie des cancers du sein non m??tastatiques??: ??tat des lieux en 2010, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.39, issue.8, pp.79-84, 2008. ,
DOI : 10.1016/j.jgyn.2010.10.005
Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future, Journal of Oncology, vol.21, issue.168, p.732047, 2013. ,
DOI : 10.1158/0008-5472.SABCS10-S3-3
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes, Journal of Clinical Oncology, vol.30, issue.15, pp.1796-1804, 2012. ,
DOI : 10.1200/JCO.2011.38.8595
Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome, J Am Coll Surg. march, vol.180, issue.3, pp.297-306, 1995. ,
Chirurgie d'ex??r??se totale du sein, 2010. ,
DOI : 10.1016/B978-2-294-06245-2.50003-6
Breast Conservation: Evolution of Surgical Strategies, The Breast Journal, vol.124, issue.s2, pp.165-173, 2006. ,
DOI : 10.1016/S0360-3016(03)00589-3
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer, New England Journal of Medicine, vol.347, issue.16, pp.1233-1241, 2002. ,
DOI : 10.1056/NEJMoa022152
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS), Annals of Oncology, vol.10, issue.1, pp.47-52, 1999. ,
DOI : 10.1023/A:1008337009350
Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18, JNCI Monographs, vol.2001, issue.30, pp.96-102, 2001. ,
DOI : 10.1093/oxfordjournals.jncimonographs.a003469
Preoperative/neoadjuvant medical therapy for early breast cancer, The Lancet Oncology, vol.2, issue.9, pp.561-570, 2001. ,
DOI : 10.1016/S1470-2045(01)00490-9
Chirurgie du cancer du sein. Traitement conservateur, oncoplastie et reconstruction. Alfred Fitoussi, 2010. ,
Chirurgie du cancer du sein. Traitement conservateur, oncoplastie et reconstruction, 2010. ,
Limiting breast surgery to the proper minimum, The Breast, vol.14, issue.6, pp.523-526, 2005. ,
DOI : 10.1016/j.breast.2005.08.008
Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study, Breast Cancer Research and Treatment, vol.19, issue.Suppl 5, pp.121-128, 2011. ,
DOI : 10.1007/s10549-010-1164-9
URL : https://hal.archives-ouvertes.fr/hal-00594469
The Epidemiology of Inflammatory Breast Cancer, Seminars in Oncology, vol.35, issue.1, pp.11-16, 2008. ,
DOI : 10.1053/j.seminoncol.2007.11.018
Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute, JNCI Journal of the National Cancer Institute, vol.97, issue.13, pp.966-975, 2005. ,
DOI : 10.1093/jnci/dji172
What progress have we made in managing inflammatory breast cancer?, Oncol Williston Park N. may, vol.21, issue.6, pp.673-679, 2007. ,
Surgical Aspects of Inflammatory Breast Cancer, Breast Disease, vol.22, issue.1, pp.67-73, 2005. ,
DOI : 10.3233/BD-2006-22108
Surgical Management of Inflammatory Breast Cancer, Seminars in Oncology, vol.35, issue.1, pp.72-77, 2008. ,
DOI : 10.1053/j.seminoncol.2007.11.008
The concept and implications of multicentricity in breast carcinoma, Pathol Annu, vol.16, pp.83-102, 1981. ,
Sections of the nipple and quadrants in mastectomy specimens for carcinoma are of limited value, Journal of Clinical Pathology, vol.58, issue.5, pp.543-545, 2005. ,
DOI : 10.1136/jcp.2004.022665
Multifocal and Multicentric Breast Cancer: Does Each Focus Matter?, Journal of Clinical Oncology, vol.23, issue.30, pp.7497-7502, 2005. ,
DOI : 10.1200/JCO.2005.02.1147
Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients, European Radiology, vol.275, issue.3, pp.692-701, 2006. ,
DOI : 10.1007/s00330-005-0043-y
Conservative surgery in patients with multifocal/multicentric breast cancer, Breast Cancer Research and Treatment, vol.353, issue.3, pp.577-583, 2009. ,
DOI : 10.1007/s10549-008-9959-7
URL : https://hal.archives-ouvertes.fr/hal-00478324
Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial, Journal of the National Cancer Institute, vol.92, issue.14, pp.1143-1150, 2000. ,
DOI : 10.1093/jnci/92.14.1143
Margin Width Should Not Still Enforce a Systematic Surgical Re-excision in the Conservative Treatment of Early Breast Infiltrative Ductal Carcinoma, Annals of Surgical Oncology, vol.9, issue.12, pp.3831-3838, 2013. ,
DOI : 10.1245/s10434-013-3063-x
Predictors of patients??? choices for breast-conserving therapy or mastectomy: a prospective study, British Journal of Cancer, vol.17, issue.11, pp.2123-2130, 2004. ,
DOI : 10.1056/NEJMoa020989
Factors influencing a woman???s choice to undergo breast-conserving surgery versus modified radical mastectomy, The American Journal of Surgery, vol.180, issue.6, pp.413-418, 2000. ,
DOI : 10.1016/S0002-9610(00)00501-8
QUALITY OF LIFE AFTER BREAST CONSERVATION OR MASTECTOMY: A SYSTEMATIC REVIEW, ANZ Journal of Surgery, vol.150, issue.11 ,
DOI : 10.1016/S0140-6736(83)91452-6
Patient evaluation of cosmetic outcome after ! 64 ,
Lumpectomy versus mastopexy--a post-surgery patient survey, Anticancer Res, vol.33, issue.2, pp.731-736, 2013. ,
Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?, European Journal of Surgical Oncology (EJSO), vol.25, issue.6, pp.571-573, 1999. ,
DOI : 10.1053/ejso.1999.0708
Breast Conservation: Evolution of Surgical Strategies, The Breast Journal, vol.124, issue.s2, pp.165-173, 2006. ,
DOI : 10.1016/S0360-3016(03)00589-3
Fear of Recurrence and Perceived Survival Benefit are Primary Motivators for Choosing Mastectomy over Breast-Conservation Therapy Regardless of Age, Annals of Surgical Oncology, vol.29, issue.16, pp.3246-3250, 2012. ,
DOI : 10.1245/s10434-012-2525-x
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre, Ann Oncol Off J Eur Soc Med Oncol ESMO. mai, vol.2, issue.5, pp.347-354, 1991. ,
Breast conservation after neoadjuvant chemotherapy. Cancer, pp.689-695, 2005. ,
Traitement locor??gional du cancer du sein inflammatoire apr??s chimioth??rapie n??oadjuvante, Cancer/Radioth??rapie, vol.15, issue.8, pp.654-662, 2011. ,
DOI : 10.1016/j.canrad.2011.01.009
New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-216, 2000. ,
DOI : 10.1093/jnci/92.3.205
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-247, 1990. ,
DOI : 10.1016/j.ejca.2008.10.026
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints, The Lancet Oncology, vol.13, issue.6, pp.240-248, 2012. ,
DOI : 10.1016/S1470-2045(11)70378-3
Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000. ,
DOI : 10.1038/35021093
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.98, issue.19, pp.10869-10874, 2001. ,
DOI : 10.1073/pnas.191367098
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis, JNCI Journal of the National Cancer Institute, vol.97, issue.3, pp.188-194, 2005. ,
DOI : 10.1093/jnci/dji021
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials, Lancet. 12 nov, vol.378, issue.9804, pp.1707-1716, 2011. ,
Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow, p.65 ,
Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902, Journal of Clinical Oncology, vol.19, issue.22, pp.4224-4237, 2001. ,
DOI : 10.1200/JCO.2001.19.22.4224
Neoadjuvant chemotherapy for operable breast cancer, British Journal of Surgery, vol.23, issue.10, pp.1189-1200, 2007. ,
DOI : 10.1002/bjs.5894
Information Needs and Decisional Preferences in Women With Breast Cancer, JAMA: The Journal of the American Medical Association, vol.277, issue.18, pp.1485-1492, 1997. ,
DOI : 10.1001/jama.1997.03540420081039
Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors, Cancer, vol.101, issue.5, pp.918-925, 2004. ,
DOI : 10.1002/cncr.20491
NSABP Trials of Adjuvant Chemotherapy for Breast Cancer, Annals of Surgery, vol.214, issue.3, pp.206-212, 1991. ,
DOI : 10.1097/00000658-199109000-00003
Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58, Clinical Breast Cancer, vol.3, issue.5, pp.333-340, 2002. ,
DOI : 10.3816/CBC.2002.n.036
Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer, Cancer, vol.23, issue.7, pp.1459-1466, 2006. ,
DOI : 10.1002/cncr.22177
Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients, Annals of Surgical Oncology, vol.127, issue.2, pp.2582-2589, 2013. ,
DOI : 10.1245/s10434-013-2909-6
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients, Breast Cancer Research and Treatment, vol.58, issue.2, pp.45-52, 2007. ,
DOI : 10.1007/s10549-006-9325-6
Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2???Positive Breast Cancer, Journal of Clinical Oncology, vol.30, issue.31, pp.3792-3799, 2012. ,
DOI : 10.1200/JCO.2011.40.0010
Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial, Journal of Clinical Oncology, vol.24, issue.19, pp.3032-3038, 2006. ,
DOI : 10.1200/JCO.2005.03.4744
HER2-Positive Breast Cancer: Update on Breast Cancer International Research Group Trials, Clinical Breast Cancer, vol.3, issue.2, pp.75-79, 2002. ,
DOI : 10.3816/CBC.2002.s.016
The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer, The American Journal of Surgery, vol.206, issue.1, pp.2-7, 2013. ,
DOI : 10.1016/j.amjsurg.2012.10.025
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy, Clinical Cancer Research, vol.11, issue.16, p.66 ,
DOI : 10.1158/1078-0432.CCR-04-2421
Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial, Annals of Oncology, vol.24, issue.8, pp.1980-1985, 2013. ,
DOI : 10.1093/annonc/mdt129
Surgery following neoadjuvant chemotherapy for Her-2 positive locally advanced breast cancer. Time to reconsider the standard attitude, 2014. ,
Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis, Journal of Clinical Oncology, vol.23, issue.9, pp.1941-1950, 2005. ,
DOI : 10.1200/JCO.2005.06.233
Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma, Annals of Surgical Oncology, vol.83, issue.6, pp.452-461, 1997. ,
DOI : 10.1007/BF02303668
Multimodality therapy in inflammatory breast cancer: is there a place for surgery?, Annals of Oncology, vol.11, issue.9, pp.1147-1153, 2000. ,
DOI : 10.1023/A:1008374931854
Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer, Radiotherapy and Oncology, vol.42, issue.3, pp.219-229, 1997. ,
DOI : 10.1016/S0167-8140(97)01923-3
Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancer, Anticancer Res. aug, vol.32, issue.8, pp.3539-3545, 2012. ,
Quality of life of breast cancer patients and types of surgery for breast cancer ??? Current status and unresolved issues ???, Breast Cancer, vol.89, issue.1, pp.66-73, 2007. ,
DOI : 10.2325/jbcs.14.66
Emotional well-being years posttreatment for breast cancer: prospective, multi-ethnic, and population-based analysis, J Cancer Surviv Res Pract. 13 nov, 2013. ,
Short-Term and Long-Term Psychosocial Adjustment and Quality of Life in Women Undergoing Different Surgical Procedures for Breast Cancer, Annals of Surgical Oncology, vol.74, issue.11, pp.3078-3089, 2007. ,
DOI : 10.1245/s10434-007-9413-9
Evaluation of quality of life and psychological response in cancer patients treated with radiotherapy, Radiation Medicine, vol.354, issue.1, pp.396-401, 2008. ,
DOI : 10.1007/s11604-008-0248-5
Early stage breast cancer: costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy, The Breast, vol.9, issue.1, pp.37-44, 2000. ,
DOI : 10.1054/brst.1999.0111
Early Effect of Surgery on Quality of Life in Women with Operable Breast Cancer, Japanese Journal of Clinical Oncology, vol.36, issue.7, pp.468-472, 2006. ,
DOI : 10.1093/jjco/hyl065
Comparison of early quality of life in patients treated with radiotherapy following mastectomy or breast conservation therapy: A prospective study, Radiotherapy and Oncology, vol.97, issue.2, pp.288-293, 2010. ,
DOI : 10.1016/j.radonc.2010.04.008
Quality of Life Following Breast-Conserving Therapy or Mastectomy: Results of a 5-Year Prospective Study, The Breast Journal, vol.65, issue.3, pp.223-231, 2004. ,
DOI : 10.1023/A:1008936830764
Locoregional Control of Clinically Diagnosed Multifocal or Multicentric Breast Cancer After Neoadjuvant Chemotherapy and Locoregional Therapy, Journal of Clinical Oncology, vol.24, issue.31, pp.4971-4975, 2006. ,
DOI : 10.1200/JCO.2006.07.6067
The management of ductal carcinoma in situ of the breast: a screened population-based analysis, Breast Cancer Research and Treatment, vol.23, issue.24, pp.335-347, 2007. ,
DOI : 10.1007/s10549-006-9302-0
Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiation Oncology, vol.2, issue.1, p.28, 2007. ,
DOI : 10.1186/1748-717X-2-28
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27, Journal of Clinical Oncology, vol.30, issue.32, pp.3960-3966, 2012. ,
DOI : 10.1200/JCO.2011.40.8369
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group, J Clin Oncol Off J Am Soc Clin Oncol. 20 jul, vol.24, issue.21, pp.3381-3387, 2006. ,
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial, The Lancet, vol.362, issue.9378, pp.95-102, 2003. ,
DOI : 10.1016/S0140-6736(03)13859-7
SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening, Acta Oncologica, vol.16, issue.5, pp.536-543, 2006. ,
DOI : 10.1016/0277-5379(90)90114-9
Carcinoma ductal in situ: correlaci??n entre la histolog??a y la resonancia magn??tica de mama, Radiolog??a, vol.51, issue.4, pp.396-402, 2009. ,
DOI : 10.1016/j.rx.2009.01.006
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study, The Lancet, vol.370, issue.9586, pp.485-492, 2007. ,
DOI : 10.1016/S0140-6736(07)61232-X
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS), Annals of Oncology, vol.10, issue.1, pp.47-52, 1999. ,
DOI : 10.1023/A:1008337009350
Pathological Assessment of the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy and Its Implications for Surgical Management, Surgery Today, vol.181, issue.3, pp.249-254, 2000. ,
DOI : 10.1007/s005950050054
The Safety of Multiple Re-excisions after Lumpectomy for Breast Cancer, Annals of Surgical Oncology, vol.14, issue.13, pp.3797-3801, 2011. ,
DOI : 10.1245/s10434-011-1802-4
Clinical practice and outcome of breast-conserving treatment: The effectiveness of preoperative systemic chemotherapy, Breast Cancer, vol.9, issue.2, pp.147-151, 2006. ,
DOI : 10.2325/jbcs.13.147
Primary Chemotherapy for Operable Breast Cancer: Incidence and Prognostic Significance of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery, Journal of Clinical Oncology, vol.19, issue.18, pp.3828-3835, 2001. ,
DOI : 10.1200/JCO.2001.19.18.3828
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17., Journal of Clinical Oncology, vol.16, issue.2, pp.441-452, 1998. ,
DOI : 10.1200/JCO.1998.16.2.441
Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma, The American Journal of Surgery, vol.182, issue.6, pp.601-608, 2001. ,
DOI : 10.1016/S0002-9610(01)00793-0
Breast Conservation Management of Breast Tumors 4 cm or Larger, Archives of Surgery, vol.127, issue.9, pp.1038-1041, 1960. ,
DOI : 10.1001/archsurg.1992.01420090042007